2|0|Public
50|$|<b>Hydromadinone</b> (INN), {{also known}} as 6α-chloro-17α-hydroxyprogesterone, is a steroidal {{progestin}} of the 17α-hydroxyprogesterone group which was patented in 1967 but was never marketed. The C17α acetate ester of <b>hydromadinone,</b> <b>hydromadinone</b> acetate, also exists, but similarly was never marketed.|$|E
50|$|<b>Hydromadinone</b> acetate (developmental {{code name}} NSC-33170), {{also known as}} chloroacetoxyprogesterone (CAP), as well as 6α-chloro-17α-acetoxyprogesterone or 6α-chloro-17α-acetoxypregn-4-ene-3,20-dione, is a steroidal {{progestin}} of the 17α-hydroxyprogesterone group that was never marketed. It is the C17α acetate ester of <b>hydromadinone,</b> which, similarly, was never marketed.|$|E

